Loading...
Expression of EZH2 is associated with poor outcome in colorectal cancer
Enhancer of zeste homolog 2 (EZH2), the critical component of polycomb group protein family, has been demonstrated to be overexpressed in various types of human cancer, including hepatocellular carcinoma, breast, bladder and lung cancer. The mechanism of how EZH2 promotes oncogenesis has also been w...
Na minha lista:
| Udgivet i: | Oncol Lett |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
D.A. Spandidos
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5778885/ https://ncbi.nlm.nih.gov/pubmed/29435024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.7647 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|